This ground-breaking biotech that is dedicated to the advancement of RNA therapies targeting chronic liver diseases is actively seeking a Site Head/Head of Late Validation to join their team. This company employs a blend of genomic deep phenotyping, precision RNA medicine, and experimentation utilizing live human donor livers to address significant challenges in liver health, including augmenting donor liver availability and mitigating complications arising from cirrhosis.
This company is headquartered out of the UK but has a flagship location in New York City and this role will report directly into the Head of the Research and Development.
Responsibilities:
Serve as the Site Head for NYC site and supervise lab staff and manage late-stage validation platforms.
Relay regular updates regarding the site and perfusion platform data
Manage the perfusion team, lab scientists, and surgical staff
Design experimental plans, workflow, and preclinical studies. Work cross-functionally with the Development team to establish workflows for perfusion samples.
Partner with recruitment and HR to facilitate hiring and benefit management.
Qualifications
PhD in life sciences with 8-10+ years of industry experience
Deep understanding of the physiology and human disease biology: specifically, experience with liver disease biology is preferred.
Extensive experience in study design for late stage preclinical projects, sample collection and management, as well as analyzing and interpreting datasets.